Efficacy and safety of ripretinib as ≥4th-line therapy for patients with gastrointestinal stromal tumor following crossover from placebo: Analyses from INVICTUS Meeting Abstract
| Authors: | Serrano, C.; Heinrich, M.; George, S.; Zalcberg, J.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Jones, R.; Attia, S.; D'Amato, G.; Chi, P.; Reichardt, P.; Meade, J.; Reichert, V.; Shi, K.; Blay, J.; von Mehren, M. |
| Abstract Title: | Efficacy and safety of ripretinib as ≥4th-line therapy for patients with gastrointestinal stromal tumor following crossover from placebo: Analyses from INVICTUS |
| Meeting Title: | ESMO 22nd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Jul 1-4 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-07-01 |
| Start Page: | S236 |
| Language: | English |
| ACCESSION: | WOS:000558722000437 |
| DOI: | 10.1016/j.annonc.2020.04.066 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O-13 -- Source: Wos |
